Loading company…
Connecticut animal health pharmaceutical company that reformulates drugs using novel delivery technologies.
Founded in 2015 and based in Connecticut, Skyline Vet Pharma, Inc., also known as SVP, researches and creates pharmaceuticals for the animal health market. It reformulates animal health drugs using novel delivery technologies, and its platform relies on veterinarian-written prescriptions. Serge Martinod, the CEO, and George Murphy founded the company. In April 2017 it raised USD 5 million in Series A financing from AgTech Accelerator, Alexandria Venture Investments, ARCH Venture Partners and Elanco Animal Health, Inc.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in